BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11421288)

  • 1. Enhanced low shear stress induced platelet aggregation by Shiga-like toxin 1 purified from Escherichia coli O157.
    Yagi H; Narita N; Matsumoto M; Sakurai Y; Ikari H; Yoshioka A; Kita E; Ikeda Y; Titani K; Fujimura Y
    Am J Hematol; 2001 Feb; 66(2):105-15. PubMed ID: 11421288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet activation by Shiga toxin and circulatory factors as a pathogenetic mechanism in the hemolytic uremic syndrome.
    Karpman D; Papadopoulou D; Nilsson K; Sjögren AC; Mikaelsson C; Lethagen S
    Blood; 2001 May; 97(10):3100-8. PubMed ID: 11342436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of combined high-performance thin-layer chromatography immunostaining and nanoelectrospray ionization quadrupole time-of-flight tandem mass spectrometry to the structural characterization of high- and low-affinity binding ligands of Shiga toxin 1.
    Meisen I; Friedrich AW; Karch H; Witting U; Peter-Katalinić J; Müthing J
    Rapid Commun Mass Spectrom; 2005; 19(24):3659-65. PubMed ID: 16285017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of Shiga toxin genes stx1, stx2, and the +93 uidA mutation of E. coli O157:H7/H-using SYBR Green I in a real-time multiplex PCR.
    Yoshitomi KJ; Jinneman KC; Weagant SD
    Mol Cell Probes; 2006 Feb; 20(1):31-41. PubMed ID: 16271448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of O157 versus non-O157 Shiga toxin-producing Escherichia coli infections in Minnesota, 2000-2006.
    Hedican EB; Medus C; Besser JM; Juni BA; Koziol B; Taylor C; Smith KE
    Clin Infect Dis; 2009 Aug; 49(3):358-64. PubMed ID: 19548834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Escherichia coli shiga-like toxins induce apoptosis and cleavage of poly(ADP-ribose) polymerase via in vitro activation of caspases.
    Ching JC; Jones NL; Ceponis PJ; Karmali MA; Sherman PM
    Infect Immun; 2002 Aug; 70(8):4669-77. PubMed ID: 12117981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Gb3 in lipid rafts in resistance to Shiga-like toxin of mutant Vero cells.
    Hanashima T; Miyake M; Yahiro K; Iwamaru Y; Ando A; Morinaga N; Noda M
    Microb Pathog; 2008 Aug; 45(2):124-33. PubMed ID: 18541402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.
    Ake JA; Jelacic S; Ciol MA; Watkins SL; Murray KF; Christie DL; Klein EJ; Tarr PI
    Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral therapeutic agents with highly clustered globotriose for treatment of Shiga toxigenic Escherichia coli infections.
    Watanabe M; Matsuoka K; Kita E; Igai K; Higashi N; Miyagawa A; Watanabe T; Yanoshita R; Samejima Y; Terunuma D; Natori Y; Nishikawa K
    J Infect Dis; 2004 Feb; 189(3):360-8. PubMed ID: 14745692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Verotoxin induced hemolytic uremic syndrome: pathophysiology of neurological involvement].
    Takagi C; Naruse T
    Nihon Rinsho; 1997 Mar; 55(3):731-5. PubMed ID: 9086789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytometric analysis of high shear-induced platelet microparticles and effect of cytokines on microparticle generation.
    Nomura S; Nakamura T; Cone J; Tandon NN; Kambayashi J
    Cytometry; 2000 Jul; 40(3):173-81. PubMed ID: 10878559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometry detection of Shiga toxins in the blood from children with hemolytic uremic syndrome.
    Tazzari PL; Ricci F; Carnicelli D; Caprioli A; Tozzi AE; Rizzoni G; Conte R; Brigotti M
    Cytometry B Clin Cytom; 2004 Sep; 61(1):40-4. PubMed ID: 15351981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of flow cytometry in an apoptosis assay to determine pH and temperature stability of shiga-like toxin 1.
    Babu US; Gaines DM; Wu Y; Westphal CD; Pereira M; Raybourne RB
    J Microbiol Methods; 2008 Oct; 75(2):167-71. PubMed ID: 18710788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cluster of hemolytic-uremic syndrome caused by Shiga toxin-producing Escherichia coli O26:H11.
    Misselwitz J; Karch H; Bielazewska M; John U; Ringelmann F; Rönnefarth G; Patzer L
    Pediatr Infect Dis J; 2003 Apr; 22(4):349-54. PubMed ID: 12690276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Escherichia coli Shiga toxin 1 enhances il-4 transcripts in bovine ileal intraepithelial lymphocytes.
    Moussay E; Stamm I; Taubert A; Baljer G; Menge C
    Vet Immunol Immunopathol; 2006 Oct; 113(3-4):367-82. PubMed ID: 16879873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postdiarrheal Shiga toxin-mediated hemolytic uremic syndrome similar to septic shock.
    Valles PG; Pesle S; Piovano L; Davila E; Peralta M; Principi I; Lo Giudice P
    Medicina (B Aires); 2005; 65(5):395-401. PubMed ID: 16296634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Low concentrations of epinephrine can augment shear stress-induced platelet aggregation].
    Goto S; Ikeda Y; Takahashi E; Handa M; Handa S
    J Cardiol; 1994; 24(3):237-41. PubMed ID: 8207639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between susceptibility to hemolytic-uremic syndrome and levels of globotriaosylceramide in human sera.
    Watarai S; Yokota K; Tana ; Kishimoto T; Kanadani T; Taketa K; Oguma K
    J Clin Microbiol; 2001 Feb; 39(2):798-800. PubMed ID: 11158156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Escherichia coli Shiga toxin 1 and TNF-alpha induce cytokine release by human cerebral microvascular endothelial cells.
    Eisenhauer PB; Jacewicz MS; Conn KJ; Koul O; Wells JM; Fine RE; Newburg DS
    Microb Pathog; 2004 Apr; 36(4):189-96. PubMed ID: 15001224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of adenosine derivatives on in vitro thrombus formation induced by shear stress.
    Menegatti M; Cristalli G; Gallo L; Mannucci PM; Pareti FI
    Haematologica; 1999 Aug; 84(8):721-5. PubMed ID: 10457408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.